Christina Sheldahl, CPA

Christina Sheldahl, CPA, has a diverse work experience spanning multiple roles in various companies. Christina is currently serving as the Associate Director of Accounting at RayzeBio since March 2022. Prior to that, Christina worked as the Interim Controller and Associate Director of SEC Reporting at Turning Point Therapeutics from October 2021 to March 2022.

Before joining Turning Point Therapeutics, Christina held the position of Director of Accounting and Financial Reporting at Secura Bio, Inc. from November 2020 to April 2021. Christina also worked as the Controller at Currax Pharmaceuticals LLC from July 2020 to November 2020 and as the Director of Accounting Assistant Controller at Sesen Bio from January 2020 to July 2020.

Christina has also gained valuable experience at Nalpropion Pharmaceuticals, Inc., where they served as the Cost Accounting Manager from June 2016 to January 2020 and later as the Controller from November 2017 to December 2019.

Their earlier experiences include serving as the Accounting Manager at Mamma Chia from June 2014 to March 2016, and as a Manager in Consulting, Audit, and Tax Services at Redfern & Company from December 2010 to June 2014.

Christina began their career as a Senior Associate at AKT LLP, CPAs and Business Consultants in December 2002. Christina has also worked at Life Technologies, where they held the roles of General Ledger Accounting Manager from November 2012 to August 2013 and CPA Auditor from November 2011 to November 2012.

Christina Sheldahl, CPA pursued their education in accountancy at Boise State University from 1998 to 1999. During this time, they completed a Bachelor of Business Administration (BBA) with a specialization in Accountancy. In addition to their degree, Christina has obtained the certification of Certified Public Accountant. However, no further details regarding the institution, month, or year of obtaining this certification are provided.